Asahi Kasei Medical to Build New Assembly Plant for Planova™ Filters | Your money

TOKYO–(BUSINESS WIRE)–February 15, 2022–

Asahi Kasei Medical has decided to increase the production capacity of Planova™ filters by building a new assembly plant in Nobeoka, Miyazaki, Japan. The new factory will be designed to realize a smart factory by accelerating manufacturing automation and digital transformation to improve production quality and efficiency. Construction is expected to begin in the third quarter of calendar year 2022 and be completed in early 2024.

This press release is multimedia. View the full press release here: https://www.businesswire.com/news/home/20220215005597/en/

Planova™ Anti-Virus Filters (Photo: Business Wire)

The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market and increased the urgent demand for Planova™ filters, which are essential for the development and commercial production of new drugs in pharmaceutical companies. Asahi Kasei Medical has taken significant steps in expanding production capacity to meet these demands. This new assembly plant follows the investment announced in 2021 for the expansion of the spinning plant of Planova™ BioEX in Oita, Japan. As for the Planova™ N series filter, the six existing plants, including the spinning plant completed in 2019 in Miyazaki, Japan, have been operating efficiently to meet the growing demand around the world.

Asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of reliable use in the production of biotherapeutic products. Asahi Kasei Medical aims to provide “Insurance Beyond Expectations” in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, scientific support and biosafety testing services to help biologics manufacturers produce safely and effectively medicines that patients can trust.

Asahi Kasei Medical will continue to strengthen its global supply infrastructure for Planova™ through proactive investments in manufacturing facilities to support the early delivery of lifesaving vaccines and therapies to as many people as possible.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220215005597/en/

CONTACT: For more information, please contact:

Shizuka Nawa

Business communication

Asahi Kasei Corp.

Phone: +81-(0)3-6699-3008

KEYWORD: CHINA UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC EUROPE

INDUSTRY KEYWORD: OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL OTHER CONSTRUCTION & PROPERTY MEDICAL DEVICES INFECTIOUS DISEASES CONSTRUCTION & PROPERTY SCIENCE BIOTECHNOLOGY MEDICAL SUPPLIES OTHER SCIENCE HEALTH

SOURCE: Asahi Kasei Corp.

Copyright BusinessWire 2022.

PUBLISHED: 2/15/2022 11:00 PM / DISK: 2/15/2022 11:02 PM

http://www.businesswire.com/news/home/20220215005597/en


Canada's Trudeau invokes emergency powers to quell protests

Copyright BusinessWire 2022.

Comments are closed.